Search company, investor...
Search

Predict your next investment

Corporation
metiscan.com

See what CB Insights has to offer

About Metiscan

Metiscan provides information management and operations support for diagnostic imaging facilities through complete revenue cycle management, electronic medical records or EMR, medical transcription services and functional training as needed.

Metiscan Headquarters Location

12225 Greenville Avenue Suite 700

Dallas, Texas, 75243,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Metiscan Acquisitions

1 Acquisition

Metiscan acquired 1 company. Their latest acquisition was Aclor on July 18, 2011.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

7/18/2011

$99M

Acquired

Date

7/18/2011

Investment Stage

Companies

Valuation

$99M

Total Funding

Note

Acquired

Sources

Metiscan Team

1 Team Member

Metiscan has 1 team member, including former Executive Vice President, Jacob Cohen.

Name

Work History

Title

Status

Jacob Cohen

Allegiance Capital

Executive Vice President

Former

Name

Jacob Cohen

Work History

Allegiance Capital

Title

Executive Vice President

Status

Former

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.